Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Auren Rx vs Coivas

Auren Rx
Graded #79

Higher grade

vs+6.7
Coivas
Graded #207

Lower grade

The verdict

Auren Rx takes it — 72.9/100 to 66.2/100.

Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAuren Rx +4
74
70
Dose & formulationEven
64
64
Clinical oversightCoivas +1
83
84
Labs & monitoringCoivas +1
53
54
FulfillmentAuren Rx +19
97
78
Contract termsAuren Rx +47
67
20
Auren Rx · left barCoivas · right bar

The numbers

MetricAuren RxCoivas
WeighScore72.9/10066.2/100
GradeCC
Scorecard rank#79#207
Semaglutide$149/mo (auto-refill; a single month with no commitment is $179)$149/mo (quarterly plan, compounded)
Tirzepatide$149/mo (auto-refill; a single month with no commitment is $179)$229/mo (quarterly plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Auren Rx

Graded #79 · C

Strengths

  • Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
  • A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
  • Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
  • Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern

Where it loses points

  • The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
  • Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
  • Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
  • The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
  • No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
  • NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Coivas

Graded #207 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard